Immunomodulatory Effects of PCSK9 Inhibition
Public ClinicalTrials.gov record NCT05720156. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
ImmuNomodulatory EffectS of PCSK9 Inhibition: A TaRgeted Molecular Imaging AppRoach
Study identification
- NCT ID
- NCT05720156
- Recruitment status
- Withdrawn
- Study type
- Observational
- Phase
- Not listed
- Lead sponsor
- Massachusetts General Hospital
- Other
- Enrollment
- Not listed
Conditions and interventions
Conditions
- Arterial Inflammation
- Atherosclerosis
- Atherosclerotic Cardiovascular Disease
- Cardiovascular Diseases
- Carotid Artery Diseases
- Carotid Atherosclerosis
- Cerebrovascular Accident
- Heart Attack
- Heart Diseases
- High Cholesterol/Hyperlipidemia
- Stroke
- Transient Ischemic Attack
- Vascular Calcification
- Vascular Disease, Peripheral
- Vascular Diseases
Interventions
- 99mTc-tilmanocept SPECT/CT scanning Other
Other
Eligibility (public fields only)
- Age range
- 18 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Accepts healthy volunteers
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 3, 2024
- Primary completion
- Feb 28, 2026
- Completion
- Feb 28, 2026
- Last update posted
- Sep 25, 2025
2024 – 2026
United States locations
- U.S. sites
- 1
- U.S. states
- 1
- U.S. cities
- 1
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Massachusetts General Hospital | Boston | Massachusetts | 02114 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05720156, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 25, 2025 · Synced May 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05720156 live on ClinicalTrials.gov.